 |
Immune Globulin Intravenous (human) |
|---|---|
| Trade Name | Carimune Nf |
| Orphan Indication | Treatment for Guillain Barre Syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2004-05-04 00:00:00 |
| Sponsor | ZLB Bioplasma AG;Wankdorfstrasse 10, CH-3000 Bern 22; |
| |
Immune Globulin Intravenous (human) |
|---|---|
| Trade Name | Carimune Nf |
| Orphan Indication | Treatment for Guillain Barre Syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2004-05-04 00:00:00 |
| Sponsor | ZLB Bioplasma AG;Wankdorfstrasse 10, CH-3000 Bern 22; |